シンポジウム: シリコン基盤技術を活用した再生医療の発展
November 11, 2025 | Nihonbashi, Tokyo
この度imecは、日本の再生医療及び細胞遺伝子治療分野のエコシステムを牽引しているLINK-J・RISE-A・JSRMと共催する形で上記シンポジウムを開催致します。本シンポジウムにおきましては、imecが培って参りましたデータドリブン、且つ自動化された、高精度なワークフローを持つ統合されたシステムを、日本の再生医療を代表される皆さまにご紹介申し上げます。
開催趣旨
再生医療、及び細胞治療分野における研究開発は、例えば生物学的なばらつき、製造拡大の難しさ、複雑化した細胞取扱手順、不完全な品質管理といった等、独自の課題に直面しております。これらの課題解決に向けて、私どもimecは半導体の専門知識を応用し、自動化、高精度化、再現性に優れた、シリコン基盤の技術解決策を研究、開発、製造の現場にグローバルに提供して参りました。
今般、私どもimecのシリコン基盤技術を、共催各位のお力添えを頂く形で、日本の再生医療及び細胞遺伝子治療の分野に従事されている皆さまに是非知って頂きたく存じます。
今回ご紹介するimecの基盤技術ポートフォリオは以下：
- ハイスループット、ラベルフリー、マルチマーカー選別を可能とするマイクロ流体及びフォトニックプラットフォームを用いた細胞分離コンセプト
- 精緻な電気穿孔を可能とする高密度MEA
- 細胞培養のリアルタイムモニタリングを目的とした統合マルチセンサーシステム
- DNA、RNA、タンパク質などを対象としたオンチップ分析法
- 生きた細胞の品質管理のためのラベルフリー高解像度コンピューテショナルイメージング・システム、等
これらのモジュール化されたテクノロジーを、細胞分離・拡大フェーズに始まり、培養モニタリング、品質管理至るまで、再生医療及び細胞治療のワークフロー全体に取り込むことで、プロセスを標準化し、大量培養体制を立上げ、治療供給体制を速やかに確立することが出来ます。
今後imecとしましては業界パートナーと緊密に連携してカスタムソリューションを共同開発することで、私どものシリコン基盤技術がいかに再生医療分野における開発の精度、再現性、拡張性を高めることが出来るかをお示し出来ると考えております。
今回の見どころ
この度ご用意させて頂いた午後のプログラムとネットワーキングレセプションに参加頂くことで、私どもの半導体基盤技術がどのように再生医療に変革をもたらし得るかを知って頂けるものと思います。ご注目頂きたい点としては以下：
- シリコン基盤技術が、再生医療及び細胞治療の製造ワークフローにおけるボトルネック（細胞分離・遺伝子導入・培養モニタリング・品質保証まで）にどのように対処できるか。
- 標準化された再現性の高い製造工程の実現に向けて、概念実証を超えた量産体制に最適なモジュールを共同開発する上で、なぜimecが理想的なパートナーであるかについて。
- ナノエレクトロニクス、センサー統合、マイクロ流体工学、高度モニタリングにおけるimecの専門性がどのように独自の形で再生医療及び細胞治療に関わるイノベーションに貢献しうるかについて。
このような方におすすめ
- 再生医療、細胞遺伝子治療、バイオ製造業界の関係者
- スタートアップ及びアカデミアの研究開発に従事されている方
- ヘルスケア、製薬、バイオテクノロジーの既存企業の研究開発に従事されている方
- 先進技術ポートフォリオや連携に関心を持つ投資家、VC、金融機関の関係者
- バイオ製造自動化やリアルタイムモニタリングに関心を持つ研究開発に従事されている方
開催プログラム（予定：14:30～19:00）
- 開会の辞 imec EVP & Chief Marketing and Communications Officer Katrien Marent
- 主催者、及び共催者代表挨拶imec、LINK-J、RISE-A、JSRM
- 基調講演：「半導体技術の力をライフサイエンスに」imec R&D Life Science Technology EVP Paru Deshpande
- 特別講演：「新しい治療のスタンダードへ-日本発の再生医療の実践とスケールアップ」日本再生医療学会・佐賀大学 中山 晃一 教授
- 一般講演：「シリコン基盤技術で再生医療を推進する」 imec Life Science Program Director Olivier Henry
- 一般講演：「グローバルテックリーダーの力を基盤にしたディープテック・ベンチャーエコシステムの構築」imec Venture Development Director Olivier Rousseaux
- 閉会の辞
- 懇親会/ ネットワーキングレセプション
- 終了
Speakers
Katrien Marent - EVP & Chief Marketing and Communications Officer, imec
Katrien Marent became imec's VP corporate, marketing and outreach communication in 2016. Since April 2020, she is Executive Vice President & Chief Marketing and Communications Officer, and member of the executive board of imec. Katrien has an engineering degree in microelectronics. She joined imec in 1992 as an analog design engineer and specialized in design of low-noise readout electronics for high-energy physics.
Shunichi Takahashi - President & COO, LINK-J
Shunichi Takahashi is President & COO of the Life Science Innovation Network Japan (LINK-J) and Visiting Professor at the University of Tsukuba. He began his career in 1993 as a researcher at a pharmaceutical company and, following mergers, joined Bayer Yakuhin, Ltd. At Bayer, he led projects in drug discovery and validation, contributed to regenerative medicine and iPS cell research, and later held leadership roles in cardiovascular project management and medical affairs. In 2014, he became head of Bayer’s Open Innovation Center Japan, where he established the center, launched CoLaborator Kobe, and built the first comprehensive partnership with Kyoto University. As a member of the Bayer Open Innovation Global Leadership Team, he advanced open innovation in Japan. In 2022, he joined LINK-J in his current role, contributing to the development of life science ecosystems in Japan.
Hiroshi Saigusa - CEO, RISE-A; Co-CEO, LINK-J; Fellow (Innovation), Mitsui Fudosan Co., Ltd.
Hiroshi Saigusa is CEO of RISE-A, Co-CEO of the Life Science Innovation Network Japan (LINK-J), and Fellow (Innovation) at Mitsui Fudosan Co., Ltd. He graduated from the Faculty of Economics at the University of Tokyo in 1989 and later earned a degree from the Graduate Schools for Law and Politics at the University of Tokyo in 1998. Hiroshi began his career at Mitsui Fudosan in 1989 and has since held a range of leadership roles across planning, research, and urban development. In 2017, he was appointed General Manager of the Life Science Innovation Department, and in 2023 became Fellow (Life Science). The following year, he was named Fellow (Innovation), a role he continues to hold alongside his leadership positions at LINK-J and RISE-A.
Paru Deshpande - VP R&D Life Sciences Technologies, imec
Paru Deshpande completed his PhD at Princeton University in polymer self-assembly for lithography. He was the first employee at BioNano Genomics, where he led projects in single-molecule DNA detection and assay development. In 2012, Paru joined imec, where he is currently Vice President of Life Science Technologies, overseeing the department’s R&D efforts.
Kazuhiko Yamamoto - Representative Director & CEO, Synplogen
Kazuhiko Yamamoto is Representative Director & CEO of Synplogen, and also Visiting Professor at Kobe University and Fellow at the UTokyo Center for Applied Capital Markets Research. He graduated from Hitotsubashi University in 1988 and began his career at Sumitomo Electric Industries and Nomura Research Institute, working in finance and management strategy. In 1998, he founded an independent venture capital firm, supporting early-stage startups while advising on M&A and corporate finance. He was appointed professor at the Graduate School of Science, Technology and Innovation at Kobe University in 2016, a position he held until 2024. He has served as director of Synplogen since 2018 and was appointed Representative Director & CEO in 2021.
Koichi Nakayama - Professor & Chairman, Saga University & Delegate, JSRM
Koichi Nakayama, M.D., Ph.D., is Professor and Chairman of the Department of Regenerative Medicine and Biomedical Engineering at Saga University’s Faculty of Medicine, and Visiting Professor at the Medical Institute of Bioregulation, Kyushu University. A former orthopedic surgeon, he has pioneered work in tissue and organ regeneration, including the development of a specialized BIO 3D printer for organ fabrication. In collaboration with industry partners, he co-founded Cyfuse Biomedical to bring bio 3D printing technology to market. He has published extensively in the field, including contributions to Biofabrication: Micro- and Nano-fabrication, Printing, Patterning and Assemblies (Elsevier, 2013). Dr. Nakayama also serves as President of the Cell Aggregation Meeting and Delegate for the Japanese Society for Regenerative Medicine.
Olivier Henry - Program Director for Life Science & Medical Device Technologies, imec
Dr. Olivier Henry is the Program Director for Life Science & Medical Device Technologies at imec, where he supports technological roadmaps and business development. His research focuses on developing integrated microdevices for diagnostics, chemical and biochemical synthesis, and cell and tissue microengineering. He holds a PhD in Biomedical Science from Cranfield University (2005). His career includes research positions at GSK, Sphere Medical, and Universitat Rovira i Virgili, as well as a Senior Staff Engineer role as part of the Advanced Technology Team at the Wyss Institute at Harvard University, where he led the Microfabrication and Sensors team. Dr. Henry has co-authored over 40 peer-reviewed publications and holds several patents in polymer and electrochemistry, microfluidics, sensing, and diagnostics.
Olivier Rousseaux - Director Venture Development, imec
Olivier Rousseaux is the Director of Venture Development at imec. He holds a PhD in Electrical Engineering from KU Leuven and an EMBA from Solvay Business School. Olivier has a background in wireless communications and venture creation and previously held roles in corporate strategy and business line management at Commscope.
Location
Rise Gate Nihonbashi,
7th Floor, 1-7-1 Nihonbashi Muromachi, Chuo-ku, Tokyo
Organizing partners
